Carmen Mak

Carmen Mak is the Vice President of Biometrics. She holds a Ph.D. in Biostatistics from the University of Toronto and a Bachelor of Mathematics from the University of Waterloo. Previously, she served as the head of the Statistical and Quantitative Sciences for the Vaccines Therapeutic Area at Takeda, where she provided statistical leadership in the submission of a dengue vaccine. At Mallinckrodt Pharmaceuticals, she was the head of Biometrics, overseeing statistical, programming, and data management for a portfolio of products including Acthar® gel and Therakos. She also led the submission and approval of Stratagraft® for deep partial thermal burns. Carmen began her career at Schering-Plough/Merck, directing statistical support of programs through all stages of clinical development and regulatory submission.